Recent Quotes (30 days)

You have no recent quotes
chg | %

Reckitt Benckiser Group Plc  

(Public, LON:RB)   Watch this stock  
Find more results forRB
4,695.70
-47.30 (-1.00%)
May 17 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 4,659.00 - 4,743.00
52 week 3,274.00 - 4,867.00
Open 4,720.00
Vol / Avg. 949,468.00/1,520.00
Mkt cap 33,691.60M*
P/E 18.69
Div/yield 78.00/2.85*
EPS 2.51*
Shares 717.50M
Beta     -
Inst. own     -
*GBP
Jul 29, 2013
H1 2013 Reckitt Benckiser plc Earnings Release Add to calendar
May 2, 2013
Reckitt Benckiser plc Annual Shareholder Meeting
Apr 22, 2013
Q1 2013 Reckitt Benckiser plc Interim Management Statement Conference Call
Apr 22, 2013
Q1 2013 Reckitt Benckiser plc Interim Management Statement
Mar 13, 2013
Reckitt Benckiser plc at Citi West Coast Institutional Investor Symposium
  

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin 21.66% 19.16%
Operating margin 27.83% 25.45%
EBITD margin - 28.41%
Return on average assets 14.50% 12.55%
Return on average equity 37.18% 31.45%
Employees 35,900 -
Carbon Disclosure Rating - 93/100

Address

103-105 Bath Road
SLOUGH, ENG SL1 3UH
United Kingdom - Map
+44-1753-217800 (Phone)
+44-1753-217899 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance
Discussion Group - Google Finance

Description

Reckitt Benckiser Group Plc is manufacturer and marketer of branded products in household, health and personal care, selling a range through over 60 operating companies into nearly 200 countries. The Company analyses its revenue based on health and personal care, fabric care, surface care, home care, dishwashing and other, together with pharmaceuticals and food. The Company�s geographical segments include: Europe, North America and Australia, Developing Markets and RB Pharmaceuticals. On February 4, 2011, it acquired a 50.1% interest in Manon Trading Company Limited (Manon). On April 11, 2011, the Company acquired Paras Pharmaceuticals Limited (Paras). The acquisition of Paras added products, such as Moov topical analgesic pain ointment, D�Cold cold/flu remedy, Dermicool for prickly heat and Krack medicated skin treatment for cracked heels. In December 2012, the Company's indirect subsidiary, Ascot Acquisition Corp. acquired Schiff Nutrition International Inc.

Officers and directors

Rakesh Kapoor Chief Executive Officer, Executive Director
Adrian N. Hennah Chief Financial Officer, Executive Director
Age: 55
Heather Allen Executive Vice President - Category Development
Salvatore Caizzone Executive Vice President, RUMEA
Freddy Caspers Executive Vice President, LAPAC
Rob de Groot Executive Vice President, ENA
Amedeo Fasano Executive Vice President - Supply
Simon Nash Senior Vice President - Human Resources
Gareth Hill Senior Vice President - Information Services
Elizabeth Richardson Company Secretary